Matthew J Ellington (Matthew Ellington)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Multidrug Resistant

Acute Kidney Injury

Top Venues

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Elita Jauneikaite, Kate Honeyford, Oliver Blandy, Mia Mosavie, Max Pearson, Farzan A Ramzan, Matthew J Ellington, Julian Parkhill, Céire E Costelloe, Neil Woodford, Shiranee Sriskandan
Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study. The Journal of antimicrobial chemotherapy 77 (6) (2022)
Francesca Martelli, Manal AbuOun, Shaun Cawthraw, Nathaniel Storey, Olivia Turner, Matthew J Ellington, Satheesh Nair, Anais Painset, Christopher Teale, Muna F Anjum
Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom. The Journal of antimicrobial chemotherapy 77 (3) (2022)
Maria Lopez-Diaz, Nicholas Ellaby, Jane Turton, Neil Woodford, Maria Tomas, Matthew J Ellington
NDM-1 carbapenemase resistance gene vehicles emergent on distinct plasmid backbones from the IncL/M family. The Journal of antimicrobial chemotherapy 77 (3) (2022)
Matthew J Ellington, Eva Heinz, Alexander M Wailan, Matthew J Dorman, Marcus de Goffau, Amy K Cain, Sonal P Henson, Nicholas Gleadall, Christine J Boinett, Gordon Dougan, Nicholas M Brown, Neil Woodford, Julian Parkhill, M Estée Török, Sharon J Peacock, Nicholas R Thomson
Contrasting patterns of longitudinal population dynamics and antimicrobial resistance mechanisms in two priority bacterial pathogens over 7 years in a single center. Genome biology 20 (1) (2019)